⌘K

Login Start Free

Home/Insiders/Pershing Edward

PE

SEC Insider//CIK 0001689739

Pershing Edward

CIK 00016897391 companyKNOXVILLE, TN

Transactions

50

Companies

1

Filings

11

CIK

0001689739

Recent Transactions

50 trades

Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Series D-1 Convertible Preferred Stock
2026-09-18+13,216→ 2,962,709 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2026-09-18
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Series D-1 Convertible Preferred Stock
2026-09-11+13,216→ 2,949,493 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2026-09-11
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2026-09-04
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Series D-1 Convertible Preferred Stock
2026-09-04+11,328→ 2,936,277 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2026-08-26
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Series D-1 Convertible Preferred Stock
2026-08-26+11,328→ 2,924,949 total
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Series D-1 Convertible Preferred Stock
2026-06-30+45,860→ 2,866,761 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Series D-1 Convertible Preferred Stock
2026-06-05+9,436→ 2,857,285 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2026-06-05
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2026-05-28
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Series D-1 Convertible Preferred Stock
2026-05-23+32,089→ 2,847,849 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2026-05-23
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2026-05-15
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Series D-1 Convertible Preferred Stock
2026-05-15+22,651→ 2,815,760 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Series D-1 Convertible Preferred Stock
2026-05-07+18,876→ 2,793,109 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2026-05-07
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Series D-1 Convertible Preferred Stock
2026-04-29+30,202→ 2,774,233 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2026-04-29
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2026-04-04
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Series D-1 Convertible Preferred Stock
2026-04-04+33,977→ 2,744,031 total
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2026-03-25
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Series D-1 Convertible Preferred Stock
2026-03-20+49,067→ 2,710,054 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2026-03-20
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2026-03-12
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2026-03-05
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2026-02-26
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2026-02-20
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Series D-1 Convertible Preferred Stock
2026-02-20+47,180→ 2,660,987 total
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2026-02-19
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2026-02-12
Purchase
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Series D-1 Convertible Preferred Stock
2026-02-09$2.86/sh+34,940→ 2,613,807 total
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2026-02-05
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2026-01-30
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Series D-1 Convertible Preferred Stock
2026-01-30+37,744→ 2,578,867 total
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2026-01-28
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2026-01-16
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Series D-1 Convertible Preferred Stock
2026-01-16+37,744→ 2,541,123 total
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2025-12-11
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2025-12-05
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2025-11-26
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2025-11-20
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2025-11-13
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2025-11-06
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2025-10-30
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2025-10-23
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2025-10-16
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Series D-1 Convertible Preferred Stock
2025-10-16+18,880→ 2,503,379 total
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2025-10-10

Companies

1

PROVECTUS BIOPHARMACEUTICALS, INC.
Director, CEO, 10% Owner
$PVCT

Recent Filings

11

Address

800 S. GAY STREET, SUITE 1610

KNOXVILLE, TN, 37929

View on SEC.gov